Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00449332 · ClinicalTrials.gov registry record
Early Indicators of Chronic Rejection in Lung Transplant
A clinical trial, sponsored by University of Chicago.
- Terminated
- Registry status
- 120
- Enrollment target
NCT00449332 is a clinical trial that was terminated before completion, run by University of Chicago. The registered enrollment target is 120 participants.
The verdict
NCT00449332 was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The purpose of this research is to discover the different patterns of cytokine production in patients who may develop Bronchiolitis Obliterans Syndrome-0p (BOS-0p) which means ongoing rejection. This is an early indicator of chronic rejection in lung transplant recipients. These cytokines can be detected in the bronchoalveolar (lung) and tissue samples of lung transplant recipients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2006-03 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00449332
The ClinicalTrials.gov registry entry for NCT00449332 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00449332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00449332 about?
NCT00449332 is a clinical study titled "Early Indicators of Chronic Rejection in Lung Transplant". The purpose of this research is to discover the different patterns of cytokine production in patients who may develop Bronchiolitis Obliterans Syndrome-0p (BOS-0p) which means ongoing rejection. This is an early indicator of chronic rejection in lung transplant recipients. These cytokines can be det...
What is the current status of trial NCT00449332?
This trial is currently terminated. The enrollment target is 120 participants. The study started on 2006-03. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT00449332?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.